調査レポート | • レポートコード：GIR-2104Z10223 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍アジュバントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍アジュバントの種類別市場規模（放射線療法、化学療法、免疫療法、ホルモン療法、標的療法、その他）、用途別市場規模（がん研究所、がん病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍アジュバントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Amgen、BMS、Biogen、Sanofi、AstraZeneca、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：放射線療法、化学療法、免疫療法、ホルモン療法、標的療法、その他 ・用途別分析2016年-2026年：がん研究所、がん病院 ・腫瘍アジュバントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍アジュバントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍アジュバントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍アジュバントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍アジュバントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology Adjuvants size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oncology Adjuvants market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oncology Adjuvants market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radiotherapy
Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapy
Others
Market segment by Application can be divided into
Cancer Research Institutes
Cancer Hospitals
The key market players for global Oncology Adjuvants market are listed below:
Eli Lilly
Amgen
BMS
Biogen
Sanofi
AstraZeneca
Pfizer
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oncology Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Adjuvants Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Radiotherapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Hormone therapy
1.2.6 Targeted therapy
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Adjuvants Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer Research Institutes
1.3.3 Cancer Hospitals
1.4 Global Oncology Adjuvants Market Size & Forecast
1.4.1 Global Oncology Adjuvants Sales in Value (2016-2026))
1.4.2 Global Oncology Adjuvants Sales in Volume (2016-2026)
1.4.3 Global Oncology Adjuvants Price by Type (2016-2026) & (USD/MT)
1.5 Global Oncology Adjuvants Production Capacity Analysis
1.5.1 Global Oncology Adjuvants Total Production Capacity (2016-2026)
1.5.2 Global Oncology Adjuvants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Adjuvants Market Drivers
1.6.2 Oncology Adjuvants Market Restraints
1.6.3 Oncology Adjuvants Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Oncology Adjuvants Product and Services
2.1.4 Eli Lilly Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Oncology Adjuvants Product and Services
2.2.4 Amgen Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 BMS
2.3.1 BMS Details
2.3.2 BMS Major Business
2.3.3 BMS Oncology Adjuvants Product and Services
2.3.4 BMS Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business
2.4.3 Biogen Oncology Adjuvants Product and Services
2.4.4 Biogen Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Oncology Adjuvants Product and Services
2.5.4 Sanofi Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Oncology Adjuvants Product and Services
2.6.4 AstraZeneca Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Oncology Adjuvants Product and Services
2.7.4 Pfizer Oncology Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oncology Adjuvants Sales by Manufacturer
3.1 Global Oncology Adjuvants Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oncology Adjuvants Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oncology Adjuvants
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Adjuvants Manufacturer Market Share
3.4.2 Top 6 Oncology Adjuvants Manufacturer Market Share
3.5 Global Oncology Adjuvants Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oncology Adjuvants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Adjuvants Market Size by Region
4.1.1 Global Oncology Adjuvants Sales in Volume by Region (2016-2026)
4.1.2 Global Oncology Adjuvants Revenue by Region (2016-2026)
4.2 North America Oncology Adjuvants Revenue (2016-2026)
4.3 Europe Oncology Adjuvants Revenue (2016-2026)
4.4 Asia-Pacific Oncology Adjuvants Revenue (2016-2026)
4.5 South America Oncology Adjuvants Revenue (2016-2026)
4.6 Middle East and Africa Oncology Adjuvants Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oncology Adjuvants Sales in Volume by Type (2016-2026)
5.2 Global Oncology Adjuvants Revenue by Type (2016-2026)
5.3 Global Oncology Adjuvants Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oncology Adjuvants Sales in Volume by Application (2016-2026)
6.2 Global Oncology Adjuvants Revenue by Application (2016-2026)
6.3 Global Oncology Adjuvants Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Adjuvants Sales by Type (2016-2026)
7.2 North America Oncology Adjuvants Sales by Application (2016-2026)
7.3 North America Oncology Adjuvants Market Size by Country
7.3.1 North America Oncology Adjuvants Sales in Volume by Country (2016-2026)
7.3.2 North America Oncology Adjuvants Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Adjuvants Sales by Type (2016-2026)
8.2 Europe Oncology Adjuvants Sales by Application (2016-2026)
8.3 Europe Oncology Adjuvants Market Size by Country
8.3.1 Europe Oncology Adjuvants Sales in Volume by Country (2016-2026)
8.3.2 Europe Oncology Adjuvants Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oncology Adjuvants Sales by Type (2016-2026)
9.2 Asia-Pacific Oncology Adjuvants Sales by Application (2016-2026)
9.3 Asia-Pacific Oncology Adjuvants Market Size by Region
9.3.1 Asia-Pacific Oncology Adjuvants Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oncology Adjuvants Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oncology Adjuvants Sales by Type (2016-2026)
10.2 South America Oncology Adjuvants Sales by Application (2016-2026)
10.3 South America Oncology Adjuvants Market Size by Country
10.3.1 South America Oncology Adjuvants Sales in Volume by Country (2016-2026)
10.3.2 South America Oncology Adjuvants Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Adjuvants Sales by Type (2016-2026)
11.2 Middle East & Africa Oncology Adjuvants Sales by Application (2016-2026)
11.3 Middle East & Africa Oncology Adjuvants Market Size by Country
11.3.1 Middle East & Africa Oncology Adjuvants Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oncology Adjuvants Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oncology Adjuvants Typical Distributors
12.3 Oncology Adjuvants Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oncology Adjuvants Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oncology Adjuvants Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Oncology Adjuvants Product and Services
Table 6. Eli Lilly Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Oncology Adjuvants Product and Services
Table 10. Amgen Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. BMS Basic Information, Manufacturing Base and Competitors
Table 12. BMS Major Business
Table 13. BMS Oncology Adjuvants Product and Services
Table 14. BMS Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biogen Basic Information, Manufacturing Base and Competitors
Table 16. Biogen Major Business
Table 17. Biogen Oncology Adjuvants Product and Services
Table 18. Biogen Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Oncology Adjuvants Product and Services
Table 22. Sanofi Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Oncology Adjuvants Product and Services
Table 26. AstraZeneca Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Oncology Adjuvants Product and Services
Table 30. Pfizer Oncology Adjuvants Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Oncology Adjuvants Sales by Manufacturer (2019-2021e) & (K MT)
Table 32. Global Oncology Adjuvants Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Oncology Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Oncology Adjuvants Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Oncology Adjuvants Production Site of Key Manufacturer
Table 36. Global Oncology Adjuvants Sales by Region (2016-2021e) & (K MT)
Table 37. Global Oncology Adjuvants Sales by Region (2021-2026) & (K MT)
Table 38. Global Oncology Adjuvants Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Oncology Adjuvants Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 41. Global Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 42. Global Oncology Adjuvants Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Oncology Adjuvants Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Oncology Adjuvants Price by Type (2016-2021e) & (USD/MT)
Table 45. Global Oncology Adjuvants Price by Type (2021-2026) & (USD/MT)
Table 46. Global Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 47. Global Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 48. Global Oncology Adjuvants Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Oncology Adjuvants Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Oncology Adjuvants Price by Application (2016-2021e) & (USD/MT)
Table 51. Global Oncology Adjuvants Price by Application (2021-2026) & (USD/MT)
Table 52. North America Oncology Adjuvants Sales by Country (2016-2021e) & (K MT)
Table 53. North America Oncology Adjuvants Sales by Country (2021-2026) & (K MT)
Table 54. North America Oncology Adjuvants Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Oncology Adjuvants Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 57. North America Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 58. North America Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 59. North America Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 60. Europe Oncology Adjuvants Sales by Country (2016-2021e) & (K MT)
Table 61. Europe Oncology Adjuvants Sales by Country (2021-2026) & (K MT)
Table 62. Europe Oncology Adjuvants Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Oncology Adjuvants Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 65. Europe Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 66. Europe Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 67. Europe Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 68. Asia-Pacific Oncology Adjuvants Sales by Region (2016-2021e) & (K MT)
Table 69. Asia-Pacific Oncology Adjuvants Sales by Region (2021-2026) & (K MT)
Table 70. Asia-Pacific Oncology Adjuvants Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Oncology Adjuvants Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 73. Asia-Pacific Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 74. Asia-Pacific Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 75. Asia-Pacific Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 76. South America Oncology Adjuvants Sales by Country (2016-2021e) & (K MT)
Table 77. South America Oncology Adjuvants Sales by Country (2021-2026) & (K MT)
Table 78. South America Oncology Adjuvants Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Oncology Adjuvants Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 81. South America Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 82. South America Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 83. South America Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 84. Middle East & Africa Oncology Adjuvants Sales by Country (2016-2021e) & (K MT)
Table 85. Middle East & Africa Oncology Adjuvants Sales by Country (2021-2026) & (K MT)
Table 86. Middle East & Africa Oncology Adjuvants Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Oncology Adjuvants Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Oncology Adjuvants Sales by Type (2016-2021e) & (K MT)
Table 89. Middle East & Africa Oncology Adjuvants Sales by Type (2021-2026) & (K MT)
Table 90. Middle East & Africa Oncology Adjuvants Sales by Application (2016-2021e) & (K MT)
Table 91. Middle East & Africa Oncology Adjuvants Sales by Application (2021-2026) & (K MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Oncology Adjuvants Typical Distributors
Table 95. Oncology Adjuvants Typical Customers
List of Figures
Figure 1. Oncology Adjuvants Picture
Figure 2. Global Oncology Adjuvants Sales Market Share by Type in 2020
Figure 3. Radiotherapy
Figure 4. Chemotherapy
Figure 5. Immunotherapy
Figure 6. Hormone therapy
Figure 7. Targeted therapy
Figure 8. Others
Figure 9. Global Oncology Adjuvants Sales Market Share by Application in 2020
Figure 10. Cancer Research Institutes
Figure 11. Cancer Hospitals
Figure 12. Global Oncology Adjuvants Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Oncology Adjuvants Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Oncology Adjuvants Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Oncology Adjuvants Sales (2016-2026) & (K MT)
Figure 34. Global Oncology Adjuvants Production Capacity (2016-2026) & (K MT)
Figure 35. Global Oncology Adjuvants Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Oncology Adjuvants Market Drivers
Figure 37. Oncology Adjuvants Market Restraints
Figure 38. Oncology Adjuvants Market Trends
Figure 39. Global Oncology Adjuvants Sales Market Share by Manufacturer in 2020
Figure 40. Global Oncology Adjuvants Revenue Market Share by Manufacturer in 2020
Figure 41. Oncology Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Oncology Adjuvants Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Oncology Adjuvants Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Oncology Adjuvants Sales Market Share by Region (2016-2026)
Figure 45. Global Oncology Adjuvants Revenue Market Share by Region (2016-2026)
Figure 46. North America Oncology Adjuvants Revenue (2016-2026) & (USD Million)
Figure 47. Europe Oncology Adjuvants Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Oncology Adjuvants Revenue (2016-2026) & (USD Million)
Figure 49. South America Oncology Adjuvants Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Oncology Adjuvants Revenue (2016-2026) & (USD Million)
Figure 51. Global Oncology Adjuvants Sales Market Share by Type (2016-2026)
Figure 52. Global Oncology Adjuvants Revenue Market Share by Type (2016-2026)
Figure 53. Global Oncology Adjuvants Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 55. Global Oncology Adjuvants Revenue Market Share by Application (2016-2026)
Figure 56. Global Oncology Adjuvants Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Oncology Adjuvants Sales Market Share by Country (2016-2026)
Figure 58. North America Oncology Adjuvants Revenue Market Share by Country (2016-2026)
Figure 59. North America Oncology Adjuvants Sales Market Share by Type (2016-2026)
Figure 60. North America Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 61. Europe Oncology Adjuvants Sales Market Share by Country (2016-2026)
Figure 62. Europe Oncology Adjuvants Revenue Market Share by Country (2016-2026)
Figure 63. Europe Oncology Adjuvants Sales Market Share by Type (2016-2026)
Figure 64. Europe Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Oncology Adjuvants Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Oncology Adjuvants Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Oncology Adjuvants Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 69. South America Oncology Adjuvants Sales Market Share by Country (2016-2026)
Figure 70. South America Oncology Adjuvants Revenue Market Share by Country (2016-2026)
Figure 71. South America Oncology Adjuvants Sales Market Share by Type (2016-2026)
Figure 72. South America Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Oncology Adjuvants Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Oncology Adjuvants Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Oncology Adjuvants Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Oncology Adjuvants Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の免疫腫瘍療法市場規模・現状・予測（2021年-2027年） Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer. Market Analysis and Insights: Global Immuno-oncology Therapy Market The global Immuno-oncology Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a …- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年） Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours. Market Analysis and Insights: Global Orthopaedic Oncology Market The global Orthopaedic Oncology market size is projected to reach US$ XX million by 2…
- 世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年） Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours. Market Analysis and Insights: Global Orthopaedic Oncology Market The global Orthopaedic Oncology market size is projected to reach US$ XX million by 2…
- 世界のがん免疫療法市場 2021：企業別、地域別、種類・用途別 The Immuno-oncology Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…